Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0Z2CY
|
||||
Former ID |
DNC005193
|
||||
Drug Name |
PLOGLITAZONE
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [527158] | ||
Structure |
Download2D MOL |
||||
Formula |
C20H21NO3S
|
||||
Canonical SMILES |
CCC1=CC=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3
|
||||
InChI |
1S/C20H21NO3S/c1-2-14-3-5-15(6-4-14)11-12-24-17-9-7-16(8-10-17)13-18-19(22)21-20(23)25-18/h3-10,18H,2,11-13H2,1H3,(H,21,22,23)
|
||||
InChIKey |
CZKMWGGUVIBIOI-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | mRNA of PPAR-gamma | Target Info | Inhibitor | [527158] | |
PANTHER Pathway | CCKR signaling map ST | ||||
WikiPathways | Wnt Signaling Pathway Netpath | ||||
Nuclear Receptors in Lipid Metabolism and Toxicity | |||||
Differentiation of white and brown adipocyte | |||||
Regulation of Lipid Metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha) | |||||
Transcriptional Regulation of White Adipocyte Differentiation | |||||
Adipogenesis | |||||
SREBP signalling | |||||
Nuclear Receptors | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.